Accumulate Glenmark Pharmaceuticals, target price Rs 460: Prabhudas Lilladher

Prabhudas Lilladher has accumulate call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 460. The current market price of Glenmark Pharmaceuticals is Rs 411.55.

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11615.45 Crore) operating in Pharmaceuticals sector.

Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2022.



Financials
For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 3472.68 Crore, up 17.30 % from last quarter Total Income of Rs 2960.44 Crore and up 10.79 % from last year same quarter Total Income of Rs 3134.38 Crore. Company reported net profit after tax of Rs 278.67 Crore in latest quarter.



Promoter/FII Holdings
Promoters held 46.65 per cent stake in the company as of 30-Jun-2022, while FIIs owned 28.54 per cent, DIIs 6.18 per cent.